Cite
HARVARD Citation
Iwata, H. et al. (2019). Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130). Japanese journal of clinical oncology. pp. 1083-1091. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Iwata, H. et al. (2019). Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130). Japanese journal of clinical oncology. pp. 1083-1091. [Online].